The antidepressant medicine sales in Italy are forecasted to grow steadily from 2024 to 2028. In 2023, sales were approximately at 710.0 million USD PPP. Year-on-year, the sector is expected to see an increase of around 2.9% from 2024 to 2025, with consistent growth observed in subsequent years, tapering off slightly as it approaches 2028. The compound annual growth rate (CAGR) over the five-year period from 2024 to 2028 is estimated at around 2.0%.
Future trends to watch for include:
- Increased acceptance and destigmatization of mental health treatments.
- Potential introduction of innovative treatment options and generic medications.
- Shifts in policy or reimbursement structures impacting access and affordability.
- Potential economic or sociocultural factors that might influence mental healthcare demand.
